Summary

Original source:
http://www.businessweek.com/ap/financialnews/D8DV40MO0.htm?campaign_id=apn_home_down&chan=db

Details

• GlaxoSmithKline PLC said Friday that it disagrees with proposed labeling changes by the Food and Drug Administration for the British drug maker's Serevent and Advair asthma treatments.
• The company said the FDA's proposed labeling changes would limit the asthma treatments for patients who had failed other treatment options first.
• GlaxoSmithKline noted that a July advisory panel to the agency had recommended no new changes to the labeling.
• The agency contends the products, which belong to a class of drugs known as long-acting beta 2-adrenergic agonists, should not be used as the first medicine to treat asthma because even though they may cut the number of asthma attacks, they may increase the chances of a more severe attack.
• Serevent was one of the five products cited by FDA whistleblower David Graham last year as posing potential dangers.
• The company counters that current labeling of the products are in line with current National Institutes of Health guidelines, and said that it will work with the agency to clear up differences of opinion regarding the drugs' benefit-to-risk profile.
• GlaxoSmithKline American depositary receipts shares fell $2.30, or 4.4 percent, to $49.75 in afternoon trading on the New York Stock Exchange.

Related Articles

Popular Topics: GlaxoSmithKline, Asthma, Labeling, Diabetes, Breast cancer, Prostate cancer, Heart disease, Depression, High cholesterol, Osteoporosis, Vaccines, Autism, ADHD, Infertility, Weight loss, Cancer, Alzheimer's, Trans fats, Acrylamides, Fluoride, Mercury	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/015470_GlaxoSmithKline_asthma_labeling.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. <a href = "http://www.NaturalNews.com/015470_GlaxoSmithKline_asthma_labeling.html">GlaxoSmithKline disagrees with FDA decision regarding Advair</a>
Receive our Natural Health Newsletter for FREE Subscribe now (it's free!) to win. We randomly choose a subscriber each month to send $100 in eco-home products or a RealGoods.com gift certificate (our choice). Plus, you'll receive FREE news, articles and action alerts from NaturalNews.com editors and join over 800,000 monthly readers who report extraordinary health improvements after becoming a subscriber! Receive breaking news alerts on natural health solutions, renewable energy, the environment, global warming and more. Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.	Your Email Address: Free Subscription Code: Enter the numbers you see: 100% free of charge. Unsubscribe anytime. Absolutely no spam. We respect your email privacy.
Recommended Special Report: Seven Words that can Change the World by Joseph R. Simonetta Read this special report now... "Seven Words That Can Change the World reveals the astonishing, simple truths that have the power to forever transform our world for the better while freeing our minds from the enslavement of limiting beliefs. This is not a text for the simple-minded; it is a guiding philosophy for the mindful, intelligent few who are wise enough to seek out -- and recognize -- the higher simplicities of truly purposeful living." - Mike Adams, the Health Ranger, editor of NaturalNews.com	More on NaturalNews.com: • Streaming Health Ranger Videos • CounterThink Cartoons • FREE Special Reports • Podcasts